Trial Profile
Bioequivalence study of atazanavir single 300 mg capsule relative to two atazanavir 150 mg capsules in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2011
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 20 Dec 2006 Status change
- 11 Nov 2006 New trial record.